Tag: United States Patent and Trademark Office
January 23, 2019
Aurora Spine Announces New Patent for Its Minimally Invasive Spinal Implants Allowed by the United States Patent Office
Aurora Spine Corporation (TSXV:ASG) announced today the issuance by the United States Patent and Trademark Office (USPTO) of United States... December 20, 2018
Glance Technologies Files Provisional Patent with USPTO
Glance Technologies (CSE:GET) announced that it has filed a provisional patent application with the United States Patent and Trademark Office.... December 19, 2018
Adamas Announces Issuance of New U.S. Patent Covering GOCOVRI
Adamas Pharmaceuticals (Nasdaq:ADMS), a fully-integrated pharmaceutical company pioneering time-dependent medicines for central nervous system (CNS) disorders, today announced that a new... December 13, 2018
Corcept Therapeutics Announces Allowance of Additional Patent Covering the Use of Korlym to Treat Patients With Cushing’s Syndrome
Corcept Therapeutics (NASDAQ:CORT) announced today that the United States Patent and Trademark Office has given notice that it will allow... December 4, 2018
Translate Bio Expands Patent Portfolio with Newly Issued U.S. Patent Relating to Its Messenger RNA Therapeutics Platform
Translate Bio (Nasdaq:TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat... November 20, 2018
New U.S. patent related to Oasmia Pharmaceutical’s nanotechnology platform XR17
Oasmia Pharmaceutical (Nasdaq:OASM) announces that the United States Patent and Trademark Office (USPTO) has issued a notification of allowance of...
November 16, 2018